Edition:
India

Zymeworks Inc (ZYME.TO)

ZYME.TO on Toronto Stock Exchange

16.90CAD
16 Nov 2018
Change (% chg)

$0.08 (+0.48%)
Prev Close
$16.82
Open
$16.74
Day's High
$16.90
Day's Low
$16.15
Volume
6,000
Avg. Vol
6,025
52-wk High
$30.36
52-wk Low
$9.37

Latest Key Developments (Source: Significant Developments)

Zymeworks Reports Q3 Loss Per Share Of $0.59
Wednesday, 7 Nov 2018 

Nov 6 (Reuters) - Zymeworks Inc ::ZYMEWORKS REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2018.ZYMEWORKS INC - REVENUE FOR THREE MONTHS ENDED SEPTEMBER 30, 2018 WAS $2.1 MILLION AS COMPARED TO $0.1 MILLION.ZYMEWORKS INC - AS OF SEPTEMBER 30, 2018, ZYMEWORKS HAD $150.0 MILLION IN CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS.ZYMEWORKS INC - QTRLY LOSS PER SHARE $0.59.  Full Article

Zymeworks Inc - QTRLY Loss Per Share $0.83
Wednesday, 2 May 2018 

Zymeworks Inc ::ZYMEWORKS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS.ZYMEWORKS INC - REVENUE FOR THREE MONTHS ENDED MARCH 31, 2018 WAS $0.04 MILLION AS COMPARED TO $0.23 MILLION IN SAME PERIOD IN 2017.ZYMEWORKS INC - EXPECTS RESEARCH AND DEVELOPMENT EXPENDITURES TO INCREASE OVER TIME.ZYMEWORKS INC - QTRLY LOSS PER SHARE $0.83.  Full Article

Zymeworks And Celgene Expand Bispecific Antibody Collaboration
Tuesday, 24 Apr 2018 

April 23 (Reuters) - Celgene Corp ::ZYMEWORKS AND CELGENE EXPAND BISPECIFIC ANTIBODY COLLABORATION.ZYMEWORKS INC - CELGENE CORP EXERCISED RIGHT TO EXPAND DEAL FOR COMMERCIALIZATION OF BISPECIFIC ANTIBODY THERAPEUTICS USING CO'S AZYMETRIC PLATFORM.ZYMEWORKS INC - ZYMEWORKS WILL RECEIVE AN EXPANSION FEE.ZYMEWORKS INC - IN TOTAL, ZYMEWORKS IS NOW ELIGIBLE TO RECEIVE UP TO $1.64 BILLION IN FUTURE PAYMENTS FOR ENTIRE COLLABORATION.ZYMEWORKS INC - CELGENE HAS EXERCISED ITS RIGHT TO INCREASE NUMBER OF POTENTIAL PRODUCTS IT CAN DEVELOP AND COMMERCIALIZE FROM EIGHT TO TEN.  Full Article

Zymeworks reports third quarter loss of $0.65 per share
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - Zymeworks Inc :Zymeworks reports third quarter 2017 financial results and provides business update.Revenues for three months ended September 30, 2017 were $0.1 million compared to $2.2 million for same period of 2016​.Qtrly ‍loss per share $0.65​.  Full Article